Periodontal Therapeutics Market Size, Share, Growth and Trends, Forecast (2024-2031)

Market Overview:

The Global Periodontal Therapeutics Market reached a size of USD 734.8 million in 2022 and is projected to nearly double by 2031, reaching USD 1,459.3 million. This market is expected to grow at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2031. The rise of teledentistry is contributing significantly to this growth by offering cost-effective solutions for both patients and dental practices.

Market Dynamics:

Drivers:

Increasing Prevalence of Periodontal Diseases: The rise in periodontal diseases such as periodontitis and gingivitis is a major driver. Periodontitis is particularly significant due to its high infection rate and severe health impacts. According to the World Health Organization (WHO), about 1 billion people globally are affected by severe periodontal disease as of 2023.

Rising R&D Investments: There is ongoing research into herbal medicines and other innovative treatments for periodontitis. For instance, AngioLab's AL201-AB, a botanical drug in phase-2 clinical trials, shows promising results in inhibiting tooth loss.

Restraints:

Preference for Surgical Procedures: The dominance of surgical and non-surgical procedures in the treatment of advanced periodontal disease can limit the market growth for therapeutic products. These traditional methods are often preferred over new therapeutic interventions.

Download Sample: https://www.datamintelligence.com/download-sample/periodontal-therapeutics-market

Market Segmentation:

By Treatment:

Systemic Antibiotics: This segment is expected to dominate the market with a share of about 54.5%. Common systemic antibiotics used include doxycycline, metronidazole, minocycline, and amoxicillin.

By Disease Type:

Periodontitis

Gingivitis

By Distribution Channel

Hospitals

Dental Clinics

Online Pharmacies

Retail Pharmacies

Geographical Analysis:

North America

North America is projected to hold the largest market share, accounting for approximately one-third of the global market. This dominance is attributed to the high prevalence of periodontal diseases, an increasing geriatric population, and a significant diabetic population. According to the American Dental Association, about 42% of U.S. adults over 30 have periodontitis. The Canadian market is also substantial, with an expected value of USD 58.66 million by 2030.
Other Regions

Europe

Asia Pacific

Latin America

Middle East and Africa

To access the complete report: https://www.datamintelligence.com/research-report/periodontal-therapeutics-market

Competitive Landscape:

The periodontal therapeutics market is highly competitive, with key players focusing on product innovation, mergers and acquisitions, and strategic collaborations.

Major players include:

Kaken Pharmaceutical Co. Ltd.

Bausch Health

Colgate-Palmolive

Medicom

Pfizer Inc.

3M

Den-Mat Holdings, LLC

Dentsply Sirona

Xttrium Laboratories, Inc.

Dexcel Pharma

Related Reports:

Dermatology Drugs Market: https://www.datamintelligence.com/research-report/dermatology-drugs-market

Pericarditis Market: https://www.datamintelligence.com/research-report/pericarditis-market

Antidepressant Drugs Market: https://www.datamintelligence.com/research-report/antidepressant-drugs-market

Anti-viral Therapeutics Market: https://www.datamintelligence.com/research-report/anti-viral-therapeutics-market

Chronic Lymphocytic Leukemia Therapeutics Market: https://www.datamintelligence.com/research-report/chronic-lymphocytic-leukemia-therapeutics-market

Oncology Therapy Market: https://www.datamintelligence.com/research-report/oncology-therapy-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: DataMIntelligence

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.